Class Action Lawsuits Filed for Multiple Companies
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 15 2026
0mins
Should l Buy LU?
Source: Globenewswire
- Lufax Shareholder Lawsuit: Shareholders of Lufax Holding Ltd. have filed a class action due to the company's failure to disclose inadequate internal controls and misstated financial results during the period from April 7, 2023, to January 26, 2025, with a lead plaintiff deadline of May 20, 2026.
- Atara Biotherapeutics Lawsuit: Atara Biotherapeutics, Inc. shareholders initiated a lawsuit for the period from May 20, 2024, to January 9, 2026, alleging undisclosed manufacturing issues and clinical trial risks that jeopardized FDA approval prospects, with a lead plaintiff deadline of May 22, 2026.
- Coty Shareholder Class Action: Coty Inc. shareholders have filed a class action due to the company's failure to disclose underperformance in its Consumer Beauty segment and slowing market growth from November 5, 2025, to February 4, 2026, with a lead plaintiff deadline of May 22, 2026.
- Legal Consultation Information: The Law Offices of Frank R. Cruz remind investors who suffered losses during these periods to contact them for legal advice to protect their rights and interests.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LU?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LU
About LU
LUFAX HOLDING LTD is a holding company mainly engaged in providing financial services for small and micro enterprises. The Company's core retail credit enablement business includes bank-funded loans, trust-funded loans and consumer finance loans. The Company is also engaged in wealth management and providing access to financial products and services. The Company conducts the business through its subsidiaries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Lufax Faces Class Action Lawsuit for Securities Fraud
- Class Action Initiated: Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Lufax and certain officers, aiming to recover damages for investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, highlighting serious concerns over corporate governance and financial transparency.
- Detailed Allegations: The complaint alleges that Lufax lacked adequate internal controls and materially misstated financial results during the class period, resulting in misleading statements about the company's business and prospects, which could undermine investor confidence and lead to stock price declines.
- Investor Action Call: Affected investors are encouraged to apply to be lead plaintiffs by May 20, 2026, allowing them to share in any potential recovery from the lawsuit, indicating that legal avenues are available for investors seeking compensation.
- Law Firm Background: Bronstein, Gewirtz & Grossman LLC is recognized for recovering hundreds of millions for investors, emphasizing its expertise in securities fraud class actions and its commitment to restoring investor capital and ensuring corporate accountability.
See More
Lufax Faces Securities Class Action Lawsuit
- Lawsuit Background: Lufax announced the removal of its auditor on January 27, 2025, due to concerns over undisclosed related-party transactions, triggering a nearly 14% drop in share price that day, reflecting severe investor concerns about the company's financial transparency.
- Internal Control Failures: The class action alleges that Lufax lacked adequate internal controls and materially misstated its financial results, which could further erode investor confidence in the company's financial health and impact its future fundraising capabilities.
- Auditor Opinion Rejection: PwC refused to consent to the incorporation of its audit opinions for 2022 and 2023 in any future company filings, indicating significant doubts about the reliability of the company's financial reporting and potentially leading to increased legal and regulatory risks.
- Investor Action Call: Hagens Berman is investigating whether Lufax intentionally violated accounting rules, urging investors who suffered significant losses to submit claims, highlighting a strong focus on corporate governance and compliance issues.
See More
Lufax Faces Class Action Lawsuit Reminder
- Class Action Reminder: The Schall Law Firm reminds investors of a class action lawsuit against Lufax for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between April 7, 2023, and January 26, 2025, with a deadline to contact the firm by May 20, 2026.
- False Statements Allegation: The complaint alleges that Lufax made false and misleading statements during the class period, failed to maintain adequate internal controls, and materially misstated financial results, leading to investor losses when the truth emerged.
- Legal Consultation Opportunity: Affected shareholders are encouraged to contact the Schall Law Firm for a free consultation regarding their rights, with provided contact details including phone and email, urging investors to participate for potential recovery.
- Lawsuit Status Explanation: The class action has not yet been certified, meaning investors are not represented by an attorney until certification occurs, and those who choose not to act will remain absent class members, potentially affecting their claims.
See More
Lufax Regains Compliance with NYSE Listing Standards
- Compliance Restoration: Lufax received confirmation from the NYSE on April 30, 2026, indicating it has regained compliance with listing standards, which enhances market confidence by removing it from the late filers list.
- Financial Reporting Submission: The company filed its 2024 20-F report on February 17, 2026, within the NYSE's extension period, ensuring compliance with the SEC and mitigating potential penalties.
- Impact of Auditor Change: The delay in filing was due to a change in auditors, but the appointment of Ernst & Young is expected to improve audit quality, thereby boosting investor confidence in the company's financial reporting.
- Funding Partnerships: Lufax has established relationships with 87 financial institutions, providing financing products tailored for small business owners, which further solidifies its leadership position in China's financial services market.
See More
Lufax Regains Compliance with NYSE Listing Standards
- Compliance Restoration: Lufax received confirmation from the NYSE on April 30, 2026, indicating it has regained compliance with continued listing standards, thereby enhancing the company's credibility in the capital markets by being removed from the late filers list.
- Financial Reporting Submission: The company filed its 2024 20-F report on February 17, 2026, within the NYSE's extension period, ensuring compliance with the SEC and avoiding potential fines and sanctions that could arise from non-compliance.
- Impact of Auditor Change: The delay in report submission was due to a change in auditors, but through collaboration with Ernst & Young, Lufax successfully completed the necessary financial audits, which bolstered investor confidence in the company's governance.
- Funding Partnerships: Lufax has established relationships with 87 financial institutions to provide financing products tailored for small business owners, further solidifying its leadership position in the Chinese financial services market.
See More
Lufax Regains Compliance with NYSE Listing Standards
- Compliance Restoration: Lufax received confirmation from the NYSE on April 30, 2026, indicating it has regained compliance with continued listing standards, successfully removing itself from the late filers' list, which enhances investor confidence.
- Financial Reporting Submission: The company timely filed its 2024 20-F report on February 17, 2026, followed by the semi-annual financials for the six-month period ended June 30, 2025 on April 30, ensuring compliance with the SEC and improving transparency.
- Impact of Auditor Change: The delay in report submission was due to a change in auditors, but Lufax successfully obtained an extension from the NYSE through collaboration with Ernst & Young, demonstrating the company's flexibility and adaptability in overcoming challenges.
- Funding Partnerships: Lufax has established long-term partnerships with 87 financial institutions, providing financing products tailored for small business owners, further solidifying its leadership position in China's financial services market and enhancing financing accessibility for small enterprises.
See More
Lufax Faces Class Action Lawsuit for Securities Fraud
- Class Action Initiated: Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Lufax and certain officers, aiming to recover damages for investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, highlighting serious concerns over corporate governance and financial transparency.
- Detailed Allegations: The complaint alleges that Lufax lacked adequate internal controls and materially misstated financial results during the class period, resulting in misleading statements about the company's business and prospects, which could undermine investor confidence and lead to stock price declines.
- Investor Action Call: Affected investors are encouraged to apply to be lead plaintiffs by May 20, 2026, allowing them to share in any potential recovery from the lawsuit, indicating that legal avenues are available for investors seeking compensation.
- Law Firm Background: Bronstein, Gewirtz & Grossman LLC is recognized for recovering hundreds of millions for investors, emphasizing its expertise in securities fraud class actions and its commitment to restoring investor capital and ensuring corporate accountability.
See More
Lufax Faces Securities Class Action Lawsuit
- Lawsuit Background: Lufax announced the removal of its auditor on January 27, 2025, due to concerns over undisclosed related-party transactions, triggering a nearly 14% drop in share price that day, reflecting severe investor concerns about the company's financial transparency.
- Internal Control Failures: The class action alleges that Lufax lacked adequate internal controls and materially misstated its financial results, which could further erode investor confidence in the company's financial health and impact its future fundraising capabilities.
- Auditor Opinion Rejection: PwC refused to consent to the incorporation of its audit opinions for 2022 and 2023 in any future company filings, indicating significant doubts about the reliability of the company's financial reporting and potentially leading to increased legal and regulatory risks.
- Investor Action Call: Hagens Berman is investigating whether Lufax intentionally violated accounting rules, urging investors who suffered significant losses to submit claims, highlighting a strong focus on corporate governance and compliance issues.
See More
Lufax Faces Class Action Lawsuit Reminder
- Class Action Reminder: The Schall Law Firm reminds investors of a class action lawsuit against Lufax for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between April 7, 2023, and January 26, 2025, with a deadline to contact the firm by May 20, 2026.
- False Statements Allegation: The complaint alleges that Lufax made false and misleading statements during the class period, failed to maintain adequate internal controls, and materially misstated financial results, leading to investor losses when the truth emerged.
- Legal Consultation Opportunity: Affected shareholders are encouraged to contact the Schall Law Firm for a free consultation regarding their rights, with provided contact details including phone and email, urging investors to participate for potential recovery.
- Lawsuit Status Explanation: The class action has not yet been certified, meaning investors are not represented by an attorney until certification occurs, and those who choose not to act will remain absent class members, potentially affecting their claims.
See More
Lufax Regains Compliance with NYSE Listing Standards
- Compliance Restoration: Lufax received confirmation from the NYSE on April 30, 2026, indicating it has regained compliance with listing standards, which enhances market confidence by removing it from the late filers list.
- Financial Reporting Submission: The company filed its 2024 20-F report on February 17, 2026, within the NYSE's extension period, ensuring compliance with the SEC and mitigating potential penalties.
- Impact of Auditor Change: The delay in filing was due to a change in auditors, but the appointment of Ernst & Young is expected to improve audit quality, thereby boosting investor confidence in the company's financial reporting.
- Funding Partnerships: Lufax has established relationships with 87 financial institutions, providing financing products tailored for small business owners, which further solidifies its leadership position in China's financial services market.
See More
Lufax Regains Compliance with NYSE Listing Standards
- Compliance Restoration: Lufax received confirmation from the NYSE on April 30, 2026, indicating it has regained compliance with continued listing standards, thereby enhancing the company's credibility in the capital markets by being removed from the late filers list.
- Financial Reporting Submission: The company filed its 2024 20-F report on February 17, 2026, within the NYSE's extension period, ensuring compliance with the SEC and avoiding potential fines and sanctions that could arise from non-compliance.
- Impact of Auditor Change: The delay in report submission was due to a change in auditors, but through collaboration with Ernst & Young, Lufax successfully completed the necessary financial audits, which bolstered investor confidence in the company's governance.
- Funding Partnerships: Lufax has established relationships with 87 financial institutions to provide financing products tailored for small business owners, further solidifying its leadership position in the Chinese financial services market.
See More
Lufax Regains Compliance with NYSE Listing Standards
- Compliance Restoration: Lufax received confirmation from the NYSE on April 30, 2026, indicating it has regained compliance with continued listing standards, successfully removing itself from the late filers' list, which enhances investor confidence.
- Financial Reporting Submission: The company timely filed its 2024 20-F report on February 17, 2026, followed by the semi-annual financials for the six-month period ended June 30, 2025 on April 30, ensuring compliance with the SEC and improving transparency.
- Impact of Auditor Change: The delay in report submission was due to a change in auditors, but Lufax successfully obtained an extension from the NYSE through collaboration with Ernst & Young, demonstrating the company's flexibility and adaptability in overcoming challenges.
- Funding Partnerships: Lufax has established long-term partnerships with 87 financial institutions, providing financing products tailored for small business owners, further solidifying its leadership position in China's financial services market and enhancing financing accessibility for small enterprises.
See More
